NOC
40
-10
PSA
58
5
ACN
70
5
GLW
48
-5
CAH
60
2
HPE
70
2
GOOGL
59
-8
LEG
31
3
VLO
42
2
XRX
34
-3
MAT
38
-3
KHC
17
4
NKE
33
2
IP
70
-3
CNP
50
-2
TRV
56
-2
HCP
70
-4
DLTR
40
4
INTC
49
16
MPC
47
3
NOC
40
-10
PSA
58
5
ACN
70
5
GLW
48
-5
CAH
60
2
HPE
70
2
GOOGL
59
-8
LEG
31
3
VLO
42
2
XRX
34
-3
MAT
38
-3
KHC
17
4
NKE
33
2
IP
70
-3
CNP
50
-2
TRV
56
-2
HCP
70
-4
DLTR
40
4
INTC
49
16
MPC
47
3
Financhill
Back

Vanda Pharmaceuticals Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
55

VNDA
Vanda Pharmaceuticals

Last Price:
5.10
Seasonality Move:
4.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Vanda Pharmaceuticals Price Quote

$5.10
-0.37 (-6.76%)
(Updated: November 14, 2024 at 4:10 PM ET)

Vanda Pharmaceuticals Key Stats

Buy
55
Vanda Pharmaceuticals (VNDA) is a Buy
Day range:
$5.37 - $5.53
52-week range:
$3.32 - $6.75
Dividend yield:
0%
P/E ratio:
135.25
P/S ratio:
1.72
P/B ratio:
0.58%
Volume:
746.8K
Avg. volume:
698K
1-year change:
60.41%
Market cap:
$315.3M
Revenue:
$192.6M
EPS:
$-0.19

How Much Does Vanda Pharmaceuticals Make?

Is Vanda Pharmaceuticals Growing As A Company?

  • What Is Vanda Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Vanda Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Vanda Pharmaceuticals Stock Price Performance

What Is Vanda Pharmaceuticals 52-Week High & Low?

Vanda Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vanda Pharmaceuticals?

Is Vanda Pharmaceuticals Cash Flow Positive?

  • What Is VNDA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.1M
  • What Is Vanda Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Vanda Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$41.9M

Vanda Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VNDA return on invested capital is -2.01%
  • What Is Vanda Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -1.69%
  • What Is VNDA Return On Equity?
    ROE is a measure of profitability and is -2.01%

Vanda Pharmaceuticals Earnings Date & Stock Price

Vanda Pharmaceuticals Competitors

  • Who Are Vanda Pharmaceuticals's Competitors?
    Below is a list of companies who compete with Vanda Pharmaceuticals or are related in some way:
    • Black Diamond Therapeutics Inc (BDTX)
    • Edgewise Therapeutics Inc (EWTX)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Zevra Therapeutics Inc (ZVRA)

Vanda Pharmaceuticals Dividend Yield

Vanda Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.59% -3.06%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.43
Upside from Last Price: 90.63%

Major Shareholders

  • How many VNDA shares are owned by institutional investors?
    66.6M VNDA shares are owned by institutional investors
  • How many VNDA shares are owned by insiders?
    4M VNDA shares are owned by insiders